CJC-1295 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-02-19. Anything still debated is marked as such rather than presented as settled.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
| Property | Value | Notes |
|---|---|---|
| Duration with linker | Several days | Reported in early human work |
| Duration without linker | Tens of minutes | Short plasma residence |
| Albumin attachment site | Cysteine-34 | Covalent maleimide reaction |
| Primary receptor | Pituitary GHRH receptor | Stimulates growth hormone release |
| Downstream marker | Insulin-like growth factor 1 | Indirect measure of activity |
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
=== Awards received in the 1990s === Keene P. Dimick Award in Chromatography, Third International Symposium on Supercritical Fluid Chromatography Award for Pioneering Work in the Development of SFC; Marcel J.E. Golay Award and Medal, International Symposium on Capillary Chromatography; American Chemical Society Award in Separation Science and Technology; American Chemical Society Exceptional Achievement Award as a Capillary Gas Chromatography Short Course Instructor; R&D 100 Award for technologically significant new product: -PAGE Polyacrylamide Gel-filled Capillaries for Capillary Electrophoresis”; Jan E. Purkynje Memorial Medal of the Czech Academy of Sciences; R&D Magazine Scientist of the Year Award; M.S. Tswett Memorial Medal of the Russian Academy of Sciences; A.J.P. Martin Gold Medal of the Chromatographic Society of Great Britain; Theophilus Redwood Award, The Royal Society of Chemistry, Great Britain; Distinguished Teaching and Mentoring Award of the University Graduate School, Indiana University; Elected as a Foreign Member of the Royal Society of Sciences (Sweden); College of Arts & Sciences Distinguished Faculty Award, Indiana University.
=== Schwentner et al. (2017) === In a 2017 molecular study, Schwentner et al. proposed a new taxon Labiocarida (derived from "labium" [Latin: lip] and "carida" [Greek: prawn]) for the clade comprising Hexapoda and Remipedia based on the presence of the functional labium in both taxa, which is consistent with other studies. The study also supports a group including Copepoda and Malacostraca in Multicrustacea.
In February 2010, the German Research Foundation published new guidelines to reduce the number of publications that could be submitted when applying for funding: "The focus has not been on what research someone has done but rather how many papers have been published and where." They noted that for decisions concerning "performance-based funding allocations, postdoctoral qualifications, appointments, or reviewing funding proposals, [where] increasing importance has been given to numerical indicators such as the h-index and the impact factor". The UK's Research Assessment Exercise for 2014 also banned the journal impact factor although evidence suggested that this ban was often ignored. In response to growing concerns over the inappropriate use of journal impact factors in evaluating scientific outputs and scientists themselves, the American Society for Cell Biology together with a group of editors and publishers of scholarly journals created the San Francisco Declaration on Research Assessment (DORA). Released in May 2013, DORA has garnered support from thousands of individuals and hundreds of institutions, including in March 2015 the League of European Research Universities (a consortium of 21 of the most renowned research universities in Europe), who have endorsed the document on the DORA website. Publishers, even those with high impact factors, also recognised the flaws.
== History == The phenomenon of prohormone conversion was discovered by Donald F. Steiner while examining the biosynthesis of insulin in 1967. At the same time, while conducting chemical sequencing of β-lipotrophic hormone (βLPH) with sheep pituitary glands Dr. Michel Chrétien determined the sequence of another hormone, melanocyte-stimulating hormone ( βMSH). This was the chemical evidence, at the level of primary protein sequence that peptide hormones could be found within larger protein molecules. The identity of the responsible enzymes was not clear for decades. In 1984, David Julius, working in the laboratory of Jeremy Thorner, identified the product of the Kex2 gene as responsible for processing of the alpha factor mating pheromone. Robert Fuller, working with Thorner, identified the partial sequence of the Kex2-homologous Furin gene in 1989. In 1990 human Kex2-homologous genes were cloned by the Steiner group, Nabil Seidah and co-workers, Wim J.M. van de Ven and co-workers, Yukio Ikehara and co-workers, Randal Kaufman and co-workers, Gary Thomas and co-workers, and Kazuhisa Nakayama and co-workers.
Sources: en.wikipedia.org
Arthritis – Types – Fibromyalgia by the CDC Fibromyalgia by the National Institute of Arthritis and Musculoskeletal and Skin Diseases Fibromyalgia by the American College of Rheumatology Fibromyalgia by the NHS
=== Liver disease === The SAM cycle has been closely tied to the liver since 1947 because people with alcoholic cirrhosis of the liver would accumulate large amounts of methionine in their blood. While multiple lines of evidence from laboratory tests on cells and animal models suggest that SAM might be useful to treat various liver diseases, as of 2012 SAM had not been studied in any large randomized placebo-controlled clinical trials that would allow an assessment of its efficacy and safety.
A soldier of FC Wing 177 was killed by insurgents in Bajaur District and another FC soldier was killed in South Waziristan, moreover an Elite Force cop was killed in Hangu District. TTP, however claimed to have conducted 16 attacks in South Waziristan, North Waziristan, Karak, Kohat, Bajaur, Peshawar, and Harnai on the day, claiming to have killed 11 Pakistani personnel. A drone strike in Mirali injured two civilians. On 2 July, Pakistani forces intercepted a drone targeting the 134 Wing of Pishin Scouts. A girls school was damaged in an insurgent attack in Bannu District, while an IED targeting a bridge was also neutralized. A drone attack in Bajaur allegedly intended at a Pakistani position, killed three civilians and wounded eight more. Two policemen were killed and one was wounded in a militant ambush in Mohmand District. Khalid Masood, a TTP commander was assassinated by "unidentified attackers" inside Afghanistan in Ghazni District. On 3 July, Pakistani forces killed three insurgents in Bajaur District, while TTP claimed to have assassinated a suspected Pakistani spy in Khyber District. JuA announced its formal split from the TTP. Two FC soldiers were killed in a Taliban sniper attack on the Do Jando border Post in Khyber District. An IED was also defused by Pakistani forces in Wana. On 5 July, heavy fighting between Pakistani and Afghan troops took place in Khyber District, following cross border fire from Afghanistan which wounded three Pakistani soldiers.
=== Ancient Greek–16th century knowledge and vernacular === Concerning historical and modern perceptions of the clitoris, the clitoris and the penis were considered equivalent by some scholars for more than 2,500 years in all respects except their arrangement. Due to it being frequently omitted from, or misrepresented in, historical and contemporary anatomical texts, it was also subject to a continual cycle of male scholars claiming to have discovered it. The ancient Greeks, ancient Romans, and Greek and Roman generations up to and throughout the Renaissance, were aware that male and female sex organs are anatomically similar, but prominent anatomists such as Galen and Vesalius regarded the vagina as the structural equivalent of the penis, except for being inverted; Vesalius argued against the existence of the clitoris in normal women, and his anatomical model described how the penis corresponds with the vagina, without a role for the clitoris. Ancient Greek and Roman sexuality additionally designated penetration as "male-defined" sexuality. The term tribas, or tribade, was used to refer to a woman or intersex individual who actively penetrated another person (male or female) through the use of the clitoris or a dildo. As any sexual act was believed to require that one of the partners be "phallic" and that therefore sexual activity between women was impossible without this feature, mythology popularly associated lesbians with either having enlarged clitorises or as incapable of enjoying sexual activity without the substitution of a phallus.
== Lipid storage == Lipids are stored in white adipose tissue as triglycerides. In a lean young adult human, the mass of triglycerides stored represents about 10–20 kilograms. Triglycerides are formed from a backbone of glycerol with three fatty acids. Free fatty acids are activated into acyl-CoA and esterified to finally reach the triglyceride droplet. Lipoprotein lipase has an important role.
Sources: en.wikipedia.org
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.
The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.
Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.